| 1 |
15.09.20 |
04.00 PM - 04.45 PM |
Christoph Wanner
Peter Stenvinkel
|
Christoph Wanner
Peter Stenvinkel
|
C. Wanner: The medium-term future of nephrology in Europe
P. Stenvinkel: COVID-19 and biomimetics: What saves the planet will save our health
|
|
| 2 |
24.09.20 |
06.30 PM - 07.15 PM |
Bernard Canaud
Franklin W. Maddux
|
Christoph Wanner
|
The renal replacement therapy landscape by 2030
|
|
| 3 |
08.10.20 |
05.00 PM - 05.45 PM |
Natalie Borman
Allan J. Collins
|
Peter Stenvinkel
|
Applying dialytic modality choices to preserve cardiovascular health: Can personalized therapy prescription deliver symptom-free dialysis? New perspectives in managing CKD patient pathway
|
|
| 4 |
29.10.20 |
06.00 PM - 06.45 PM |
Francesca Mallamaci
Giovanni Tripepi
|
Christoph Wanner
|
Excersize and outcomes in dialysis patients
|
|
| 5 |
05.11.20 |
05.00 PM - 05.45 PM |
Charles Chazot
Jule Pinter
|
Peter Stenvinkel
|
Sodium, volume and pressure control in stage 5 chronic kidney disease dialysis patients: A new tryptic to improve cardiac outcome
|
|
| 6 |
19.11.20 |
05.00 PM - 05.45 PM |
Dick de Zeeuw
|
Christoph Wanner
|
Precision Medicine: A clinical decision support system to tailor therapy and improve renal and cardiovascular outcomes using a multiple parameter response score. Change of daily clinical care?
|
|
| 7 |
03.12.20 |
05.00 PM - 05.45 PM |
Jeroen Kooman
Len Usvyat
|
Peter Stenvinkel
|
Wearable health devices and personal area networks: Can they improve outcomes in haemodialysis patients?
|
|
| 8 |
17.12.20 |
05.00 PM - 05.45 PM |
Håkan Hedman
Norbert Lameire
|
Christoph Wanner
|
Expanding the patient's voice in nephrology with patient outcome measures
|
|
| 9 |
14.01.21 |
05.00 PM - 05.45 PM |
Marie Evans
Kai Lopau
|
Peter Stenvinkel
|
The transition clinic in CKD care
|
|
| 10 |
11.02.21 |
05.00 PM - 05.45 PM |
Maria F. Slon Roblero
maxence Ficheux
|
Christoph Wanner
|
Home dialysis - Focus on cardiovascular protection
|
|
| 11 |
11.03.21 |
05.00 PM - 05.45 PM |
Kitty Jager
Raphaël Duivenvoorden
|
Christoph Wanner
|
ERA-EDTA registry - Focus ERA-CODA study: Overview, first results and what we can learn from different approaches on COVID-19
|
|
| 12 |
08.04.21 |
05.00 PM - 05.45 PM |
Lili Chan
|
Peter Stenvinkel
|
Machine Learning in nephrology
|
|
| 13 |
22.04.21 |
05.00 PM - 05.45 PM |
Wim Van Biesen
Ariane Zaloszyc
|
Christoph Wanner
|
Approaches to tailored dialysis modality choices
|
|
| 14 |
05.05.21 |
05.00 PM - 06.00 PM |
Bernard Canaud
Andrew Davenport
Simon Davies
|
Peter Stenvinkel
|
Sodium management in ESKD and dialysis
|
|
| 15 |
01.06.21 |
05.00 PM - 05.45 PM |
Speaker (TBD)
|
Christoph Wanner
|
COVID-19 vaccines, drugs, ongoing trials, how far have we come
|
|
| 16 |
01.07.21 |
05.00 PM - 05.45 PM |
Adeera Levin
Christoph Wanner
|
Peter Stenvinkel
|
A. Levin: Bringing the recent findings into perspective for nephrology
C. Wanner: Diabetic nephropathy - New results-revolution
|
|
| 17 |
05.08.21 |
05.00 PM - 05.45 PM |
Nadja Grobe
Peter Kotanko
|
Christoph Wanner
|
Precision medicine @ Renal Research Institute
|
|
| 18 |
01.09.21 |
05.00 PM - 05.45 PM |
Franklin W. Maddux
Stefano Stuard
|
Peter Stenvinkel
|
Perspectives from a large dialysis provider: Lessons learned from 18 months after the COVID-19 pandemic
|
|
